 |
|
|
|||||
Indian banks are poised for a tepid September quarter with muted earnings and loan growth, driven by a slowdown in retail and corporate segments. Analysts anticipate weaker treasury gains and potential net interest margin compression due to rising bond yields and recent repo rate cuts. Asset quality in SME and commercial vehicle segments remains a key concern.
Category:
News and Media
Indian pharmaceutical companies are set for a steady September quarter. Growth in the US generics market and domestic sales will drive performance. Companies like Apollo Hospitals, Lupin, and Aurobindo are expected to show strong results. Despite some cost pressures, the sector anticipates positive medium-term prospects. New product launches and expanding facilities will support earnings.
Category:
News and Media
Nifty eyes further upside, potentially crossing 25,45025,500, with banking and consumption stocks showing promise. Analysts suggest Nifty should sustain above 24,900, while a move past 25,440 could target 25,700. Investors are advised to look for opportunities in sectors like banking, auto, metal, and consumption.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||